Belgium· BE-AMP-SAM509475-00
Vemlidy 25 mg
A tenofovir alafenamide product containing tenofovir alafenamide fumarate, registered in Belgium by Gilead Sciences Ireland UC. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Tenofovir alafenamide is registered in 14 of 19 countries.
Countries holding a registration under ATC J05AF13 (tenofovir alafenamide), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Tenofovir alafenamide · ATC J05AF13
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tenofovir alafenamide costs, country by country.
Normalised to the WHO defined daily dose (25 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tenofovir alafenamide · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- CH Switzerland$20.29
- IT Italy$18.37
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Tenofovir Alafenamide Fumarate
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Belgium (BE)
- ATC code
- J05AF13
- ATC class
- Tenofovir alafenamide
- Defined daily dose
- 25 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb7720998
- be_apb3536943EUR 292.27
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tenofovir alafenamide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandVemlidyParanova Oy
- NorwayVemlidyGilead Sciences Ireland UC
- CzechiaVEMLIDYGilead Sciences Ireland UC, Carrigtohill
- IcelandVemlidyGilead Sciences Ireland UC*
- NetherlandsTenofoviralafenamide Devatis 25 mg, filmomhulde tablettenDevatis GmbH
- PolandVemlidyGilead Sciences Ireland UC
- SwitzerlandVemlidy, FilmtablettenGilead Sciences Switzerland Sàrl
- SwedenVemlidy 25 mg Filmdragerad tablettGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Tenofoviralafenamid Devatis
- Iceland · Vemlidy
- Liechtenstein · Vemlidy
- Netherlands · Tenofoviralafenamide Devatis
- Norway · Vemlidy
- Portugal · Tenofovir Alafenamida Humanis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/02289e57-7202-4db7-a6c3-3f3b60fd576c GET /v1/drugs/02289e57-7202-4db7-a6c3-3f3b60fd576c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Vemlidy 25 mg",
"name_fr": "Vemlidy 25 mg",
"name_nl": "Vemlidy 25 mg",
"amp_code": "SAM509475-00",
"strengths": [
"25.0000",
"95.0000"
],
"pack_count": 2,
"substances": [
"Tenofovir Alafenamide Fumarate",
"Tenofovir Alafenamide",
"Lactose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Tenofovir alafenamide",
"authorisation_numbers": [
"EU/1/16/1154/001",
"EU/1/16/1154/002"
]
}See everything about tenofovir alafenamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.